Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pancreatic Adenocarcinoma × niraparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ovarian Neoplasms 19 Neoplasms 7 Fallopian Tube Neoplasms 6 Breast Neoplasms 5 Prostatic Neoplasms 4 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Mesothelioma 2 Uveal Melanoma 1 Uterine Neoplasms 1 Urothelial Cancer 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Unilateral Breast Neoplasms 1 Triple Negative Breast Neoplasms 1 Solid Tumor 1 Sarcoma, Ewing 1 Recurrence 1 Prostatic Diseases 1 Prostate Carcinoma Metastatic to the Bone 1 Prostate Adenocarcinoma 1 Platinum-resistant Recurrent Clear Cell Ovarian Cancer 1 Pancreatic Adenocarcinoma 1 Ovarian Diseases 1 Mesothelioma, Malignant 1 Melanoma 1 Leukemia, Prolymphocytic, T-Cell 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 HER2-negative Metastatic Breast Cancer 1 Gonadal Disorders 1

Interventions

Gemcitabine 5 130-nm albumin-bound paclitaxel 4 Fluorouracil 3 Albumin-Bound Paclitaxel 3 dehydroftorafur 2 Taxes 2 Oxaliplatin 2 tocilizumab 1 selicrelumab 1 niraparib 1 cobimetinib 1 atezolizumab 1 Tiragolumab 1 Resistance Training 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Image-Guided 1 Radiotherapy, Conformal 1 Pancreatectomy 1 PEGPH20 1 Nivolumab 1 Leucovorin 1 Irinotecan 1 Ipilimumab 1 Interleukin 1 Receptor Antagonist Protein 1 Electronic Health Records 1 Cisplatin 1 Bevacizumab 1 4-fluorobenzoyl-TN-14003 1 3-aminopyridine-2-carboxaldehyde thiosemicarbazone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03404960 2025-10-10

Parpvax

University of Pennsylvania

Phase 1/2 Completed

104 enrolled 11 charts

Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡